Publications by authors named "Xingfei Lv"
Article Synopsis
- The study assessed the effects of various antidiabetic medications on diabetes patients infected with COVID-19, using data from multiple research databases.
- Results showed that treatments like Metformin, DPP4 inhibitors, SGLT2 inhibitors, and GLP1 receptor agonists were linked to lower COVID-19 mortality rates, while insulin was associated with higher mortality.
- Overall, the research concluded that certain antidiabetic medications might help reduce the risk of COVID-19 mortality in diabetic patients, while others, like insulin, could pose additional risks, and there was no significant link between the medications and severe disease risk.